|
|
Volumn 15, Issue 4, 2001, Pages 290-291
|
|
The cost of psoriasis treatment
a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIPOTRIOL;
CLOBETASONE;
COAL TAR;
CORTICOSTEROID DERIVATIVE;
CYCLOSPORIN A;
DITHRANOL;
ETRETIN;
ETRETINATE;
FLUOCINONIDE;
GENERIC DRUG;
METHOTREXATE;
TAZAROTENE;
TRIAMCINOLONE ACETONIDE;
CONTROLLED STUDY;
COST CONTROL;
COST OF ILLNESS;
DRUG BIOAVAILABILITY;
DRUG CAPSULE;
DRUG COST;
ECONOMIC ASPECT;
EDITORIAL;
HEALTH CARE COST;
HOSPITAL COST;
HOSPITALIZATION;
HUMAN;
ITALY;
OINTMENT;
OUTPATIENT CARE;
PHOTOTHERAPY;
PREVALENCE;
PRIORITY JOURNAL;
PRODUCTIVITY;
PSORIASIS;
PSORIATIC ARTHRITIS;
PSYCHOLOGICAL ASPECT;
PUSTULAR PSORIASIS;
PUVA;
TUBE;
ULTRAVIOLET B RADIATION;
UNITED ARAB EMIRATES;
UNITED STATES;
DRUG COSTS;
HEALTH CARE COSTS;
HOSPITALIZATION;
HUMANS;
ITALY;
PSORIASIS;
UNITED ARAB EMIRATES;
UNITED STATES;
|
|
EID: 0034748737
PISSN: 09269959
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1468-3083.2001.00257.x Document Type: Editorial |
|
Times cited : (16)
|
|
References (0)
|